Cargando…

Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies

Mitochondria are the main site of intracellular synthesis of ATP, which provides energy for various physiological activities of the cell. Cardiomyocytes have a high density of mitochondria and mitochondrial damage is present in a variety of cardiovascular diseases. In this paper, we describe mitocho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yafei, Zhou, Bingying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216385/ https://www.ncbi.nlm.nih.gov/pubmed/37239170 http://dx.doi.org/10.3390/biomedicines11051500

Ejemplares similares

Oxidative Toxicity in Neurodegenerative Diseases: Role of Mitochondrial Dysfunction and Therapeutic Strategies
por: Facecchia, Katie, et al.
Publicado: (2011)

Mitochondrial Dysfunction, Oxidative Stress, and Therapeutic Strategies in Diabetes, Obesity, and Cardiovascular Disease
por: Cojocaru, Karina-Alexandra, et al.
Publicado: (2023)

Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects
por: Rey, Federica, et al.
Publicado: (2021)

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases
por: Liu, Yu, et al.
Publicado: (2022)

Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation
por: Tang, Xiaoli, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Diseases, Longevity, and Treatment Resistance: Tuning Mitochondria Function as a Therapeutic Strategy
por: Tomita, Kazuo, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Cardiac Arrhythmias
por: Deng, Jielin, et al.
Publicado: (2023)

Diagnostic Strategies for Early Recognition of Cancer Therapeutics–Related Cardiac Dysfunction
por: Manrique, Carlos R, et al.
Publicado: (2017)

The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
por: Huang, Xiaoyang, et al.
Publicado: (2022)

Mitochondrial Transplantation as a Novel Therapeutic Strategy for Mitochondrial Diseases
por: Park, Anna, et al.
Publicado: (2021)

Deciphering Cardiac Biology and Disease by Single-Cell Transcriptomic Profiling
por: Wang, Le, et al.
Publicado: (2022)

Mitochondrial dysfunction of induced pluripotent stem cells-based neurodegenerative disease modeling and therapeutic strategy
por: Luo, Hong-Mei, et al.
Publicado: (2022)

Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Chronic Respiratory Diseases: Implications for the Pathogenesis and Potential Therapeutics
por: Zhou, Wen-cheng, et al.
Publicado: (2021)

Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies
por: Xiang, Chen, et al.
Publicado: (2022)

Mitochondrial dysfunction and Alzheimer’s disease: prospects for therapeutic intervention
por: Lim, Ji Woong, et al.
Publicado: (2020)

Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation
por: Madireddy, Sahithi, et al.
Publicado: (2023)

The Multi-Faceted Nature of Renalase for Mitochondrial Dysfunction Improvement in Cardiac Disease
por: Stojanovic, Dijana, et al.
Publicado: (2023)

Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
por: Henrich, Martin T., et al.
Publicado: (2023)

Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease
por: Rahman, Md. Ataur, et al.
Publicado: (2020)

Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation
por: Middleton, Paul, et al.
Publicado: (2021)

New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
por: Disatnik, Marie-Hélène, et al.
Publicado: (2015)

Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy
por: Foo, Aaron Song Chuan, et al.
Publicado: (2020)

Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases
por: Sun, Mingchu, et al.
Publicado: (2023)

Mitochondrial Dysfunction and Diabetic Nephropathy: Nontraditional Therapeutic Opportunities
por: Zhang, Ping Na, et al.
Publicado: (2021)

Mitochondrial Dysfunction and Therapeutic Targets in Auditory Neuropathy
por: Feng, Baoyi, et al.
Publicado: (2020)

Mitochondrial dysfunction in kidney injury, inflammation, and disease: potential therapeutic approaches
por: Bhatia, Divya, et al.
Publicado: (2020)

The mitochondrial calcium uniporter: a new therapeutic target for Parkinson’s disease-related cardiac dysfunctions?
por: Scorza, Fúlvio Alexandre, et al.
Publicado: (2020)

Potential therapy strategy: targeting mitochondrial dysfunction in sepsis
por: Zhang, Hui, et al.
Publicado: (2018)

Mitochondrial biology and dysfunction in secondary mitochondrial disease
por: Baker, Megan J., et al.
Publicado: (2022)

Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
por: Onyango, Isaac G.
Publicado: (2018)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Therapeutic strategies in ischemic cardiomyopathy: Focus on mitochondrial quality surveillance
por: Chang, Xing, et al.
Publicado: (2022)

Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress
por: Yamada, Yuma, et al.
Publicado: (2020)

Adrenal Dysfunction in Mitochondrial Diseases
por: Corkery-Hayward, Madeleine, et al.
Publicado: (2023)

Mitochondrial dysfunction in Parkinson’s disease
por: Hu, Qingsong, et al.
Publicado: (2016)

Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Age Related Macular Degeneration, Role in Pathophysiology, and Possible New Therapeutic Strategies
por: Bilbao-Malavé, Valentina, et al.
Publicado: (2021)

Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects
por: Toker, Lilach, et al.
Publicado: (2015)

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
por: Izzo, Antonella, et al.
Publicado: (2018)

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
por: Buneeva, Olga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3cce1l1ej24oeofbps5cj02jf3